Added to YB: 2025-08-12
Pitch date: 2025-08-09
LOVE.V [neutral]
Cannara Biotech Inc.
-2.07%
current return
Author Info
No bio for this author
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 183.9M
Pitch Price
CAD 1.93
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.53
P/E
16.11
EV/Sales
1.80
Sector
Personal Care Products
Category
growth
Cannara Biotech's Quiet Triumph: Efficiency Gains and Market Maneuvers
LOVE.V (earnings update): Record Q2 w/ revenue +44%, AEBITDA, profit & FCF. Market up 23%, but LOVE gaining share in QC (12.3%), BC & SK, flat in ON, declining in AB. Efficiency gains boosted production from 40K to 50K kg/yr without new rooms. QC vapes coming, retail penetration up to 2.7%. Operating at 6.22% interest rate. 15 more rooms by 2029.
Read full article (26 min)